Key facts
| Price (PPV) | 262 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | carvedilolivabradine |
| Class | Beta blocking agents |
| ATC code | C07FX06 |
| Manufacturer | SERVIER MAROC |
| Presentation | Boite de 28 |
| Hospital price | 164.20 MAD |
| Data collected on | 9/8/2026 |
Indications
Association indiquée dans le traitement de l’insuffisance cardiaque chronique (classes NYHA II à IV) avec dysfonction systolique en substitution chez les patients adultes en rythme sinusal et contrôlés par la prise concomitante et à la même posologie d’ivabradine et de carvédilol.
Find an open pharmacy
On-call pharmacies near you
About Carivalan 12.5 mg / 5 mg
Carivalan 12.5 mg / 5 mg belongs to the beta blocking agents therapeutic class. In Morocco, this drug is marketed by SERVIER MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Carivalan 12.5 mg / 5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Carivalan 12.5 mg / 5 mg
Answers to common questions from Moroccan patients about this drug.